411 related articles for article (PubMed ID: 17057711)
1. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.
Tegeder I; Costigan M; Griffin RS; Abele A; Belfer I; Schmidt H; Ehnert C; Nejim J; Marian C; Scholz J; Wu T; Allchorne A; Diatchenko L; Binshtok AM; Goldman D; Adolph J; Sama S; Atlas SJ; Carlezon WA; Parsegian A; Lötsch J; Fillingim RB; Maixner W; Geisslinger G; Max MB; Woolf CJ
Nat Med; 2006 Nov; 12(11):1269-77. PubMed ID: 17057711
[TBL] [Abstract][Full Text] [Related]
2. The tetrahydrobiopterin pathway and pain.
Naylor AM; Pojasek KR; Hopkins AL; Blagg J
Curr Opin Investig Drugs; 2010 Jan; 11(1):19-30. PubMed ID: 20047156
[TBL] [Abstract][Full Text] [Related]
3. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype.
Tegeder I; Adolph J; Schmidt H; Woolf CJ; Geisslinger G; Lötsch J
Eur J Pain; 2008 Nov; 12(8):1069-77. PubMed ID: 18374612
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care.
Doehring A; Freynhagen R; Griessinger N; Zimmermann M; Sittl R; Hentig Nv; Geisslinger G; Lötsch J
Clin J Pain; 2009; 25(9):781-5. PubMed ID: 19851158
[TBL] [Abstract][Full Text] [Related]
5. GCH1, BH4 and pain.
Latremoliere A; Costigan M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1728-41. PubMed ID: 21466440
[TBL] [Abstract][Full Text] [Related]
6. Mast cell tetrahydrobiopterin contributes to itch in mice.
Zschiebsch K; Fischer C; Wilken-Schmitz A; Geisslinger G; Channon K; Watschinger K; Tegeder I
J Cell Mol Med; 2019 Feb; 23(2):985-1000. PubMed ID: 30450838
[TBL] [Abstract][Full Text] [Related]
7. Cell-autonomous role of endothelial GTP cyclohydrolase 1 and tetrahydrobiopterin in blood pressure regulation.
Chuaiphichai S; McNeill E; Douglas G; Crabtree MJ; Bendall JK; Hale AB; Alp NJ; Channon KM
Hypertension; 2014 Sep; 64(3):530-40. PubMed ID: 24777984
[TBL] [Abstract][Full Text] [Related]
8. Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.
Antoniades C; Cunnington C; Antonopoulos A; Neville M; Margaritis M; Demosthenous M; Bendall J; Hale A; Cerrato R; Tousoulis D; Bakogiannis C; Marinou K; Toutouza M; Vlachopoulos C; Leeson P; Stefanadis C; Karpe F; Channon KM
Circulation; 2011 Oct; 124(17):1860-70. PubMed ID: 21969008
[TBL] [Abstract][Full Text] [Related]
9. Impaired behavioural pain responses in hph-1 mice with inherited deficiency in GTP cyclohydrolase 1 in models of inflammatory pain.
Nasser A; Bjerrum OJ; Heegaard AM; Møller AT; Larsen M; Dalbøge LS; Dupont E; Jensen TS; Møller LB
Mol Pain; 2013 Feb; 9():5. PubMed ID: 23421753
[TBL] [Abstract][Full Text] [Related]
10. Analgesia by inhibiting tetrahydrobiopterin synthesis.
Costigan M; Latremoliere A; Woolf CJ
Curr Opin Pharmacol; 2012 Feb; 12(1):92-9. PubMed ID: 22178186
[TBL] [Abstract][Full Text] [Related]
11. The neurobiology of tetrahydrobiopterin biosynthesis: a model for regulation of GTP cyclohydrolase I gene transcription within nigrostriatal dopamine neurons.
Kapatos G
IUBMB Life; 2013 Apr; 65(4):323-33. PubMed ID: 23457032
[TBL] [Abstract][Full Text] [Related]
12. Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk.
Doehring A; Antoniades C; Channon KM; Tegeder I; Lötsch J
Mutat Res; 2008; 659(3):195-201. PubMed ID: 18515178
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous mutations in GTP-cyclohydrolase-1 reduce BH4 biosynthesis but not pain sensitivity.
Nasser A; Møller AT; Hellmund V; Thorborg SS; Jespersgaard C; Bjerrum OJ; Dupont E; Nachman G; Lykkesfeldt J; Jensen TS; Møller LB
Pain; 2018 Jun; 159(6):1012-1024. PubMed ID: 29470312
[TBL] [Abstract][Full Text] [Related]
14. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function.
Antoniades C; Shirodaria C; Van Assche T; Cunnington C; Tegeder I; Lötsch J; Guzik TJ; Leeson P; Diesch J; Tousoulis D; Stefanadis C; Costigan M; Woolf CJ; Alp NJ; Channon KM
J Am Coll Cardiol; 2008 Jul; 52(2):158-65. PubMed ID: 18598896
[TBL] [Abstract][Full Text] [Related]
15. [Regulations and pathophysiological significance of the biosynthesis of tetrahydrobiopterin in human endothelial cells].
Shiraishi H; Ohtsuki M; Sumi-Ichinose C; Nomura T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):73P-75P. PubMed ID: 12491785
[TBL] [Abstract][Full Text] [Related]
16. Effects of depletion of intracellular tetrahydrobiopterin in murine erythroleukemia cells.
Zhuo S; Fan S; Kaufman S
Exp Cell Res; 1996 Jan; 222(1):163-70. PubMed ID: 8549660
[TBL] [Abstract][Full Text] [Related]
17. Functional tetrahydrobiopterin synthesis in human platelets.
Franscini N; Bachli EB; Blau N; Fischler M; Walter RB; Schaffner A; Schoedon G
Circulation; 2004 Jul; 110(2):186-92. PubMed ID: 15197144
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells.
Shi W; Meininger CJ; Haynes TE; Hatakeyama K; Wu G
Cell Biochem Biophys; 2004; 41(3):415-34. PubMed ID: 15509890
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of tetrahydrobiopterin attenuates testicular damage by reducing nitric oxide synthase activity in a cryptorchid mouse model.
Kondo Y; Ishikawa T; Yamaguchi K; Yada T; Fujisawa M
J Androl; 2008; 29(2):153-63. PubMed ID: 17978343
[TBL] [Abstract][Full Text] [Related]
20. Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation.
McNeill E; Crabtree MJ; Sahgal N; Patel J; Chuaiphichai S; Iqbal AJ; Hale AB; Greaves DR; Channon KM
Free Radic Biol Med; 2015 Feb; 79():206-16. PubMed ID: 25451639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]